This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Beijing Immunochina Pharmaceuticals Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Mengmeng Liang - Innovator in Chimeric Antigen Receptor Optimization
Introduction
Mengmeng Liang is a notable inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the optimization of chimeric antigen receptors. His work is crucial for advancements in targeted therapies for various diseases.
Latest Patents
Mengmeng Liang holds a patent for the "Optimization of Chimeric Antigen Receptor." This innovation is pivotal in enhancing the efficacy of immunotherapies, which are increasingly important in modern medicine. He has 1 patent to his name, showcasing his commitment to advancing scientific knowledge.
Career Highlights
Currently, Mengmeng Liang is employed at Beijing Immunochina Pharmaceuticals Co., Ltd. His role at the company allows him to apply his expertise in developing innovative solutions in the pharmaceutical industry. His work is instrumental in pushing the boundaries of what is possible in medical treatments.
Collaborations
Mengmeng has collaborated with talented individuals such as Ting He and Feifei Qi. These partnerships highlight the importance of teamwork in the research and development process, fostering an environment where innovative ideas can flourish.
Conclusion
Mengmeng Liang's contributions to the field of biotechnology, particularly through his patent on chimeric antigen receptors, demonstrate his dedication to innovation. His work at Beijing Immunochina Pharmaceuticals Co., Ltd. and collaborations with other professionals further emphasize the impact of teamwork in advancing medical science.